Teodora Dimcheva

Prof. Dr. Teodora Dimcheva

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2025 in Diseases
Verified
Journal Article
Open access
PDF file
Ivanka Nikolova PaskalevaIvanka Nikolova Paskaleva
Ivanka Nikolova Paskaleva
NKNartsis N. Kaleva
Nartsis N. Kaleva
TDTeodora Dimcheva
Teodora Dimcheva
PMPETYA Petkova MARKOVA
PETYA Petkova MARKOVA
ИИИван Иванов
Иван Иванов
Background: The ketogenic diet has been successfully used in the last 100 years in the treatment of epilepsy and other neurological disorders. In recent decades, it gained wider application in the treatment of obesity, metabolic syndrome, and type 2 diabetes. However, there have been only a few studies on its use in children with obesity and associated metabolic disorders. Objectives: To determine the clinical and metabolic effects of a well-formulated low-carbohydrate (ketogenic) diet in children with obesity. Methods: One hundred children with obesity and metabolic disorders underwent initial anthropometric, laboratory, and ultrasound examinations. They were placed on a well-formulated ketogenic diet and monitored for 4 months. The 58 patients who completed the study underwent follow-up examinations to assess the effects of the diet on anthropometric, clinical, and laboratory markers of metabolic syndrome and insulin resistance, cardiovascular risk factors, and certain hormone levels. Compliance with the diet, common difficulties in adhering to it, side effects, and positive changes in the patients’ health were analyzed. Results: At the end of the study, the average weight loss for the entire group was 6.45 kg, with a reduction in BMI of 3.12 kg/m2. Significant improvements were also observed in insulin resistance indicators, including fasting insulin levels, HOMA-IR index, QUICKI (p < 0.0001), and adiponectin (p = 0.04). The cases of hepatosteatosis decreased twofold, the number of patients with arterial hypertension was significantly reduced, as well as the number of children receiving antihypertensive therapy. Additionally, the number of patients meeting the criteria for metabolic syndrome decreased threefold. Conclusions: A well-formulated short-term ketogenic diet is effective in treating obesity, metabolic syndrome, and related comorbidities, and can be part of a comprehensive approach for these patients.

30 June 2023 in Folia Medica
Verified
Journal Article
Open access
PDF file
ABAlexandra Baldzhieva
Alexandra Baldzhieva
HBHasan Burnusuzov
Hasan Burnusuzov
MMMariana A. Murdjeva
Mariana A. Murdjeva
TDTeodora Dimcheva
Teodora Dimcheva
HTHristo B. Taskov
Hristo B. Taskov
Minimal residual disease refers to a leukemia cell population that is resistant to chemotherapy or radiotherapy and leads to disease relapse. The assessment of MRD is crucial for making an accurate prognosis of the disease and for the choice of optimal treatment strategy. Here, we review the advantages and disadvantages of the available genetic and phenotypic methods and focus on the multiparametric flow cytometry as a promising method with greater sensitivity, speed, and standardization options. In addition, we discuss how the application of automated data analysis outweighs the use of complex combinations of windows and gates in classical analysis, thus eliminating subjective evaluation.

30 June 2023 in Folia Medica
Verified
Journal Article
Open access
PDF file
AAAndreana Angelova
Andreana Angelova
MAMariya Atanasova
Mariya Atanasova
KKKostadin Ketev
Kostadin Ketev
ZHZeyra Halil
Zeyra Halil
IPIvanka Paskaleva
Ivanka Paskaleva
MMMariana Murdjeva
Mariana Murdjeva
The Coronavirus Disease 2019 (COVID-19) caused by a novel coronavirus (SARS-CoV-2) affects mainly older adults. Those with comorbidities are at a higher risk of severe disease and even death. The symptomatic infection rate of children is lower, manifestations are milder, and severe forms are scarce. We present here two children with severe COVID-19 and a respiratory syncytial virus, with the goal of emphasizing the possibility of coinfection with a severe course and a different result. The microbiological diagnosis was made using multiplex PCR. This assay not only provided an early and accurate diagnosis but also aided in the implementation of contact precautions. Further research should be done to determine the influence of coinfection on the clinical course and outcome of pediatric patients.

14 September 2021 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
VHVelizar Hadzhiminev
Velizar Hadzhiminev
LPLybomir Paunov
Lybomir Paunov
TDTeodora Dimcheva
Teodora Dimcheva
AUAngel Uchikov
Angel Uchikov
INIvan Novakov
Ivan Novakov
Spontaneous pneumothorax (SP) is a rare complication of COVID-19 pneumonia; it affects both intubated and non-intubated patients. The pathogenesis includes barotrauma and pneumatocele formation. In the following article, we present case series of 18 patients with COVID-19 associated pneumothorax - a detailed demographic and clinical analysis were performed. The study revealed that men were more affected than women, especially above the age of 55 years; whilst, the distribution of intubated patients and those with spontaneous breathing were equal. Importantly, tube thoracostomy was the preferred method of treatment. The lethal outcome was observed in all patients on mechanical ventilation, due to the severe course of the underlying disease. The occurrence of pneumothorax in patients with COVID-19 is associated with poorer outcome of the disease, especially in those placed on mechanical ventilation.

4 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Ivanka Nikolova PaskalevaIvanka Nikolova Paskaleva
Ivanka Nikolova Paskaleva
NKNartsis Nisim Kaleva
Nartsis Nisim Kaleva
TDTeodora Dimcheva
Teodora Dimcheva
PMPETYA Petkova MARKOVA
PETYA Petkova MARKOVA
ИИИван Иванов
Иван Иванов
Background: Ketogenic diet has been successfully used in the last 100 years in the treatment of epilepsy and other neurological disorders. In recent decades, it gained wider application in the treatment of obesity, metabolic syndrome, and type 2 diabetes. However, there have been only a few studies on its use in children with obesity and associated metabolic disorders. Objectives: To determine the clinical and metabolic effects of a well-formulated low-carbohydrate (ketogenic) diet in children with obesity. Methods: One hundred children with obesity and metabolic disorders underwent initial anthropometric, laboratory, and ultrasound examinations. They were placed on a well-formulated ketogenic diet and monitored for 4 months. The 58 patients who completed the study underwent follow-up examinations to assess the effects of the diet on anthropometric, clinical, and laboratory markers of metabolic syndrome and insulin resistance, cardiovascular risk factors, and certain hormone levels. Compliance with the diet, common difficulties in adhering to it, side effects, and positive changes in the patients' health were analyzed. Results: At the end of the study, the average weight loss for the entire group was 6.45 kg, with a reduction in BMI of 3.12 kg/m². Significant improvements were also observed in insulin resistance indicators, including fasting insulin levels, HOMA-IR index, QUICKI (P<0.0001), and adiponectin (P=0.04). The cases of hepatosteatosis decreased twofold, the number of patients with arterial hypertension was significantly reduced, as well as the number of children receiving antihypertensive therapy. Additionally, the number of patients meeting the criteria for metabolic syndrome decreased threefold. Conclusion: A well-formulated short-term ketogenic diet is effective in treating obesity, metabolic syndrome, and related comorbidities, and can be part of a comprehensive approach for these patients.

2 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Ivanka Nikolova PaskalevaIvanka Nikolova Paskaleva
Ivanka Nikolova Paskaleva
NKNarstis Nisim Kaleva
Narstis Nisim Kaleva
TDTeodora Dimcheva
Teodora Dimcheva
ИИИван Иванов
Иван Иванов
Background: For decades, the ketogenic diet has been successfully used for the treatment of obesity, metabolic syndrome, and type 2 diabetes. The mechanisms through which it affects metabolism are not fully understood, but the hormonal changes that occur during ketogenic nutrition are likely to play an important role. Methods: One hundred children aged 8–18 years with obesity were enrolled. After baseline anthropometric, biochemical, and hormonal testing, they followed a 4-month “well-formulated ketogenic diet.” Fifty-eight of them successfully com-pleted the study with follow-up assessments. Among them, 8 girls had polycystic ovary syndrome (PCOS) and 7 children had Hashimoto’s autoimmune thyroiditis. Results: At the end of the 4-month period, there was a significant decrease in basal insulinemia (p< 0.0001) and in mean morning cortisol levels (p=0.04), as well as an increase in adiponectin levels (p=0.04). All girls with PCOS experienced spontaneous menstrual cycles, accompanied by a reduction in testosterone levels. TSH levels showed no change for the whole group (p=0.13), but there was a significant decrease in T3 (p< 0.0001) and a mild increase in T4 (p=0.05). Among patients with Hashimoto’s thyroiditis, TSH levels were significantly higher at the end of the study. Conclusions: A short-term, "well-formulated ketogenic” diet in children with obesity induces hormonal changes that support weight loss and improve insulin sensitivity. The diet shows particularly beneficial effects in girls with PCOS and may be considered as part of a comprehensive therapeutic approach in these patients. Monitoring thyroid function during ketogenic nutrition is advisable in patients with hypothyroidism and thyroid disorders.